← Back to Clinical Trials
Recruiting NCT06627387

NCT06627387 A Low-Cost Balance Training Platform Using Augmented Reality in Neurorehabilitation: a Usability Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06627387
Status Recruiting
Phase
Sponsor Hospital Universitari Vall d'Hebron Research Institute
Condition Postural Balance
Study Type INTERVENTIONAL
Enrollment 15 participants
Start Date 2024-08-06
Primary Completion 2025-01-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Balance Training Using Augmented Reality

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 15 participants in total. It began in 2024-08-06 with a primary completion date of 2025-01-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to assess the Usability, adherence, acceptance, and security of an augmented reality platform for balance training in patients with balance disorders due to degenerative injuries or cerebrovascular diseases. The main questions it aims to answer are: * Is the augmented reality system usable, acceptable, and safe with good adherence? * Does the system improve the balance in our population? * Participants will be asked to assist at Vall d'Hebrón Hospital, where patients will undergo balance training under the supervision of a physiotherapist three days a week for four weeks. * If the patients meet the inclusion criteria, the intervention will be extended for two more weeks at home.

Eligibility Criteria

Inclusion Criteria: * Balance impairment due cerebrovascular diseases or neurodegenerative diseases. * Being able to mantain standing for 2 minuts without assistance. * Berg scale ≥21 * Age ≥18 * Signing informed consent * To have a training partner during the exercises at home. * No fall attempt during hospital intervention * No have enough space to train safely at their home. * Being familiar with technological devices such a laptop, tablets or inteligent cellphones. Exclusion Criteria: * The presence of a condition or abnormality that could compromise the patient's safety. * Severe cognitive impairments tha prevent the execution of the xperiment (MoCA \<19) * Presence of sensory aphasia. * Diagnostic of conduct disorders. * Presence of severe neglect. * Spasticity =4 in MAS lower limb.

Contact & Investigator

Central Contact

Susana Rodriguez Gonzalez, MD

✉ susana.rodriguezgonzalez@vallhebron.cat

📞 +34 607609067

Principal Investigator

Susana Rodriguez Gonzalez, MD

PRINCIPAL INVESTIGATOR

VHIR

Frequently Asked Questions

Who can join the NCT06627387 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Postural Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06627387 currently recruiting?

Yes, NCT06627387 is actively recruiting participants. Contact the research team at susana.rodriguezgonzalez@vallhebron.cat for enrollment information.

Where is the NCT06627387 trial being conducted?

This trial is being conducted at Barcelona, Spain.

Who is sponsoring the NCT06627387 clinical trial?

NCT06627387 is sponsored by Hospital Universitari Vall d'Hebron Research Institute. The principal investigator is Susana Rodriguez Gonzalez, MD at VHIR. The trial plans to enroll 15 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology